title: [Clinical effects of intravenous ciprofloxacin on community-acquired pneumonia with positive Immunocard Mycoplasma test results].
abstract: We studied the clinical effects of intravenous ciprofloxacin (CPFX) on community-acquired pneumonia in patients with positive Immunocard Mycoplasma test results. The subjects were 35 patients (59.4 +/- 24.8 years old) with community-acquired pneumonia with positive Immunocard Mycoplasma test results. We infused CPFX 300mg copy intravenously twice daily for 3-14 days. It was effective in 33 of 35 patients, with an efficacy rate of 94.3%. Adverse reactions consisted of itching in 2 patients, malaise in 2 patients, drug eruption in 1 patient, elevation of GPT in 1 patient and elevation of BUN in 1 patient, but all were mild. We conclude that intravenous CPFX is useful for community-acquired pneumonia in case with positive Immunocard Mycoplasma test results.
authors.affiliation: Center of Respiratory Diseases, Kawasaki Medical School, Kawasaki Hospital.
authors.forename: Niro
authors.initials: N
authors.lastname: Okimoto
authors.forename: Fumiyo
authors.initials: F
authors.lastname: Nanba
authors.forename: Takashi
authors.initials: T
authors.lastname: Kibayashi
authors.forename: Michihiro
authors.initials: M
authors.lastname: Kishimoto
authors.forename: Kenji
authors.initials: K
authors.lastname: Yamato
authors.forename: Takeyuki
authors.initials: T
authors.lastname: Kurihara
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Honda
authors.forename: Kohichi
authors.initials: K
authors.lastname: Osaki
authors.forename: Naoko
authors.initials: N
authors.lastname: Asaoka
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage* / Q000009:adverse effects; D015415:Biomarkers / Q000097:blood; D002939:Ciprofloxacin / Q000008:administration & dosage* / Q000009:adverse effects; D017714:Community-Acquired Infections / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D007075:Immunoglobulin M / Q000097:blood; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009174:Mycoplasma / Q000276:immunology; D009175:Mycoplasma Infections / Q000175:diagnosis* / Q000188:drug therapy*; D018410:Pneumonia, Bacterial / Q000175:diagnosis* / Q000188:drug therapy*; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D015415:Biomarkers; D007075:Immunoglobulin M; D002939:Ciprofloxacin